WallStreetZenWallStreetZen

NASDAQ: EXOZ
Exozymes Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Exozymes earnings were -$9.7M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest EXOZ earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$2.4M, down 10.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, EXOZ reported annual earnings of -$9.2M, with 56.3% growth.

EXOZ earnings history

Current Revenue
$0.0
Current Earnings
-$9.7M
Current Profit Margin
0%

EXOZ Return on Equity

Current Company
-220.6%
Current Industry
-142%
Current Market
13.5%
EXOZ's Return on Equity (-220.6%)... subscribe to Premium to read more.
High Return on Equity Performance

EXOZ Return on Assets

Current Company
-141.3%
Current Industry
-13.7%
EXOZ is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when EXOZ announces earnings.

EXOZ Return on Capital Employed

Current Company
-397.93%
Current Industry
-9.5%

EXOZ vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
EXOZ-$9.34M-$9.67MN/A-$1.14
HYPD-$26.70M-$35.49MN/A-$9.70
XLO-$29.91M-$31.30MN/A-$2.55
IMMPN/A-$59.52MN/A-$0.41
CNTX-$40.10M-$40.23MN/A-$0.42
View Top Biotech Stocks

Exozymes Earnings Reports & History FAQ

What were Exozymes's earnings last quarter?

Exozymes (NASDAQ: EXOZ) reported Q1 2026 earnings per share (EPS) of -$0.28, up 27.27% year over year. Total EXOZ earnings for the quarter were -$2.37 million. In the same quarter last year, Exozymes's earnings per share (EPS) was -$0.22.

If you're new to stock investing, here's how to buy Exozymes stock.

Is Exozymes profitable or losing money?

As of the last Exozymes earnings report, Exozymes is currently losing money. Exozymes's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$9.67 million, a 44.17% increase year over year.

What was EXOZ's earnings growth in the past year?

As of Exozymes's earnings date in Q2 2026, Exozymes's earnings has grown year over year. EXOZ earnings in the past year totalled -$9.67 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.